• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 99-113 of 133 results

1045 Exhibit: MYLAN EX 1045 Qiu et al

Document IPR2017-01034, No. 1045 Exhibit - MYLAN EX 1045 Qiu et al (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1033 Exhibit: MYLAN EX 1033 Svensson et al

Document IPR2017-01034, No. 1033 Exhibit - MYLAN EX 1033 Svensson et al (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1012 Exhibit: MYLAN EX 1012 Markman Opinion and Order

Document IPR2017-01034, No. 1012 Exhibit - MYLAN EX 1012 Markman Opinion and Order (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

JGY2DLWARXEAPX4

Document Controlled Release and Taste Masking Oral Pharmaceutical Composition, 13/617,138, No. JGY2DLWARXEAPX4 (U.S. Pat. App. May. 8, 2018)

cite Cite Document
Analyze

1022 Exhibit: MYLAN EX 1022 PCT International Publication No WO 9636318

Document IPR2017-01034, No. 1022 Exhibit - MYLAN EX 1022 PCT International Publication No WO 9636318 (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1016 Exhibit: MYLAN EX 1016 Amendment and Response to Office Action

Document IPR2017-01034, No. 1016 Exhibit - MYLAN EX 1016 Amendment and Response to Office Action (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1047 Exhibit: MYLAN EX 1047 Uceris¿¿ website

Document IPR2017-01034, No. 1047 Exhibit - MYLAN EX 1047 Uceris¿¿ website (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1025 Exhibit: MYLAN EX 1025 FDA Inactive Ingredient Guide 19961997

Document IPR2017-01034, No. 1025 Exhibit - MYLAN EX 1025 FDA Inactive Ingredient Guide 19961997 (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1009 Exhibit: MYLAN EX 1009 US Patent No 5,811,388

Document IPR2017-01034, No. 1009 Exhibit - MYLAN EX 1009 US Patent No 5,811,388 (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1038 Exhibit: MYLAN EX 1038 Daly et al

Document IPR2017-01034, No. 1038 Exhibit - MYLAN EX 1038 Daly et al (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1058 Exhibit: MYLAN EX 1058 Applicant Initiated Interview Summary of April 23, 20...

Document IPR2017-01034, No. 1058 Exhibit - MYLAN EX 1058 Applicant Initiated Interview Summary of April 23, 2013 in US Patent Appl No 13617,138 (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1051 Exhibit: MYLAN EX 1051 LW Doner

Document IPR2017-01034, No. 1051 Exhibit - MYLAN EX 1051 LW Doner (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1052 Exhibit: MYLAN EX 1052 Amendment filed on January 15, 2013 in US Patent ...

Document IPR2017-01034, No. 1052 Exhibit - MYLAN EX 1052 Amendment filed on January 15, 2013 in US Patent Appl No 13617,138 (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1053 Exhibit: MYLAN EX 1053 Specification of US Patent Application No 10009,53...

Document IPR2017-01034, No. 1053 Exhibit - MYLAN EX 1053 Specification of US Patent Application No 10009,532 (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1062 Exhibit: MYLAN EX 1062 N Robinson, Surface Interaction of Lecithin and Lys...

Document IPR2017-01034, No. 1062 Exhibit - MYLAN EX 1062 N Robinson, Surface Interaction of Lecithin and Lysolecithin, J of Pharmacy and Pharmacology (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 7 8 9 10 >>